Cis-platinum complex with retained prolactin receptor specific binding
Hecquet, B.; Peyrat, J.P.; Bonneterre, J.; Demaille, A.
Biomedicine and PharmacoTherapy 37(5): 236-239
1983
ISSN/ISBN: 0753-3322 PMID: 6318847 Document Number: 204882
Two complexes of prolactin and platinum have been synthetized and their biological activity was assayed by radioreceptor assay. Only the cis-platinum prolactin complex retains the capacity of native prolactin to bind to cell receptor membrane. Prolactin could be used to increase the specificity of cis-platinum to cells with prolactin receptors.
Document emailed within 1 workday
Related Documents
Rosa, A.A.; Djiane, J.; Houdebine, L.M.; Kelly, P.A. 1982: Stimulatory effects of prolactin and anti-prolactin receptor serum on prolactin binding sites in rat liver cells in suspension culture Biochemical and Biophysical Research Communications 106(1): 243-249Cech, S.Y.; Maguire, M.E. 1982: Magnesium regulation of the beta-receptor-adenylate cyclase complex. I. Effects of manganese on receptor binding and cyclase activation Molecular Pharmacology 22(2): 267-273
Hwang, S.B.; Lam, M.H.; Hsu, A.H. 1989: Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors Molecular Pharmacology 35(1): 48-58
Ehlert, F.J.; Roeske, W.R.; Yamamura, S.H.; Yamamura, H.I. 1983: The benzodiazepine receptor: complex binding properties and the influence of GABA Advances in Biochemical Psychopharmacology 36: 209-220
Kensler, T.W.; Busby, W.F.; Davidson, N.E.; Wogan, G.N. 1976: Effect of hepatocarcinogens on the binding of glucocorticoid-receptor complex in rat liver nuclei Cancer Research 36(12): 4647-4651
Zukin, S.R.; Zukin, R.S. 1980: (3H)-Phencyclidine binding to specific brain receptor sites Psychopharmacology Bulletin 16(4): 59-62
Taran, E.A.; Ivanovskaia, M.G.; Gait, M.J.; Shabarova, Z.A. 1998: Covalent binding of RNA with peptides in the structure of a specific complex using N-oxybenzotriazole oligoribonucleotide esters Molekuliarnaia Biologiia 32(5): 832-839
Stämpfli, M.R.; Rudolf, M.; Miescher, S.; Pachlopnik, J.M.; Stadler, B.M. 1995: Antigen-specific inhibition of IgE binding to the high-affinity receptor Journal of Immunology 155(6): 2948-2954
London, E.D.; Coyle, J.T. 1979: Specific binding of [3H]kainic acid to receptor sites in rat brain Molecular Pharmacology 15(3): 492-505
Zak-Nejmark, T.; Małolepszy, J.; Nadobna, G.; Kuczyńska-Sekieta, K.; Marczyńska-Sarul, E.; Jutel, M. 1992: Specific immunotherapy stimulates the binding of histamine H2 receptor antagonist by lymphocytes Archivum Immunologiae et Therapiae Experimentalis 40(2): 113-116
Blanchard, S.G.; Lee, P.H.; Pugh, W.W.; Hong, J.S.; Chang, K.J. 1987: Characterization of the binding of a morphine (mu) receptor-specific ligand: Tyr-Pro-NMePhe-D-Pro-NH2, [3H]-PL17 Molecular Pharmacology 31(4): 326-333
Davis, W.C.; Ticku, M.K. 1981: Ethanol enhances [3H]diazepam binding at the benzodiazepine-gamma-aminobutyric acid receptor-ionophore complex Molecular Pharmacology 20(2): 287-294
Lim, J.-h.; Kim, T.-y.; Kim, W.-h.; Park, J.-w. 2011: CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways Breast Cancer Research and Treatment 130(1): 19-27
Rademaker, B.; Kramer, K.; Bast, A.; Timmerman, H. 1988: Irreversible binding of the fluorescent beta-adrenoceptor probes alprenolol-NBD and pindolol-NBD to specific and non-specific binding sites Research Communications in Chemical Pathology and Pharmacology 60(2): 147-159
Marano, N.; Holowka, D.; Baird, B. 1989: Bivalent binding of an anti-CD3 antibody to Jurkat cells induces association of the T cell receptor complex with the cytoskeleton Journal of Immunology 143(3): 931-938
Miller, L.G.; Greenblatt, D.J.; Roy, R.B.; Summer, W.R.; Shader, R.I. 1988: Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function Journal of Pharmacology and Experimental Therapeutics 246(1): 177-182
Pascuzzo, G.J.; Akaike, A.; Maleque, M.A.; Shaw, K.P.; Aronstam, R.S.; Rickett, D.L.; Albuquerque, E.X. 1984: The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties Molecular Pharmacology 25(1): 92-101
Porschke, D.; Hillen, W.; Takahashi, M. 1984: The change of DNA structure by specific binding of the cAMP receptor protein from rotation diffusion and dichroism measurements EMBO Journal 3(12): 2873-2878
Romeo, E.; Cavallaro, S.; Korneyev, A.; Kozikowski, A.P.; Ma, D.; Polo, A.; Costa, E.; Guidotti, A. 1993: Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex Journal of Pharmacology and Experimental Therapeutics 267(1): 462-471
Hamann, A.; Jablonski-Westrich, D.; Scholz, K.U.; Duijvestijn, A.; Butcher, E.C.; Thiele, H.G. 1988: Regulation of lymphocyte homing. I. Alterations in homing receptor expression and organ-specific high endothelial venule binding of lymphocytes upon activation Journal of Immunology 140(3): 737-743